Literature DB >> 3806422

A family study of patients with attention deficit disorder and normal controls.

J Biederman, K Munir, D Knee, W Habelow, M Armentano, S Autor, S K Hoge, C Waternaux.   

Abstract

In a family study of Attention Deficit Disorder (ADD), we collected data on first-degree relatives of 22 children with ADD and 20 normal children. The morbidity risk for ADD was 31.5% in the first group. This was significantly higher than the rate of 5.7% in the control group. Relatives of ADD probands were also shown to be at higher risk for Oppositional Disorders and Major Depressive Disorder (MDD). The findings indicate that ADD is a familial disorder associated with increased familial risk of other psychiatric disorders.

Entities:  

Mesh:

Year:  1986        PMID: 3806422     DOI: 10.1016/0022-3956(86)90030-0

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  5 in total

Review 1.  Hyperactivity in children: a focus on genetic research and psychological theories.

Authors:  J Kuntsi; J Stevenson
Journal:  Clin Child Fam Psychol Rev       Date:  2000-03

2.  Associations between clinic-referred boys and their fathers on childhood inattention-overactivity and aggression dimensions.

Authors:  J Loney; C E Paternite; J E Schwartz; M A Roberts
Journal:  J Abnorm Child Psychol       Date:  1997-12

3.  Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence.

Authors:  A Thapar; A Hervas; P McGuffin
Journal:  Behav Genet       Date:  1995-11       Impact factor: 2.805

4.  Transgenerational transmission of hyperactivity in a mouse model of ADHD.

Authors:  Jinmin Zhu; Kevin P Lee; Thomas J Spencer; Joseph Biederman; Pradeep G Bhide
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

5.  Attention deficit hyperactivity disorder and blood lead levels in Chinese children.

Authors:  Jack Brondum
Journal:  Environ Health Perspect       Date:  2009-07       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.